In addition, JWA alone or in combination with related molecular markers (XRCC1, p53, MDM2, FAK) can predict the prognosis of tumor patients and the sensitivity to chemotherapy drugs [80,90,91,92,93,94]. The gene discussed is PTK2; the disease is neoplasm.